Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland.
Edoardo BotteriNathalie C StøerElisabete WeiderpassEero PukkalaOlavi YlikorkalaHeli LyytinenPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
Our results add to the growing body of epidemiologic evidence that the use of unopposed estrogens in menopause increases the risk of cutaneous melanoma, while the addition of progestins might counteract the detrimental effect.